Have you heard about this thing they're calling the Female Viagra? Yeah, me too. The drug Flibanserin (sold as Addyi) was just approved by the FDA to treat women for the somewhat sketchy 'disease' of hypoactive sexual desire disorder, described as a sudden loss of libido [Edited to add that loss of libido is a very real thing that can happen to both men and women. However, this condition was removed from the DSM a few years ago and is not longer considered a disorder. Homosexuality used to be in the DSM as well.]
There's been a lot of back and forth about its effectiveness (minimal), the way it works (nothing like Viagra which pumps penises full of blood, as opposed to working on the brain), and the PR campaign that got it approved after multiple attempts (killer, unfortunately).
I've been skeptical of this drug ever since I first heard about it from the The New View Campaign and the documentary Orgasm, Inc, both of which address the medicalization of female sexuality. Here are some reasons why you might be skeptical as well.
We live in a society that continues to judge a woman both for being too sexual and not sexual enough, that defines good sex as whatever pleases a woman's male partner, and only counts vaginal orgasms through intercourse as 'real' orgasms (thanks, Dr. Freud). Also, sex is complicated and talking about it can be difficult, so taking a little pill every day may feel a lot less messy.
There's been a lot written this week, so I've compiled some of the most interesting writing about this Lady Viagra phenomenon, as well some thoughts on women and desire. Let me know what you think!
First, me! Sady Doyle's Guardian article gave me the last word on the meaning of 'normal' when we talk about sex:
“When it comes to sex, there is no ‘normal. There’s no right way to have sex for the first time, no timetable for sexual experiences, no perfect amount of sex to have, and no requirement to even have sex at all. Saying ‘normal’ exists, and ‘normal’ is a moving target depending on who you ask, means there’s something wrong with anyone who doesn’t conform. Meaning, all of us.”
Speaking of 'normal,' FiveThirtyEight suggests that accurate statistics might help more than drugs:
"Inaccurate perceptions about what counts as normal sexuality are widespread. In sociologist Michael Kimmel’s book “Guyland: The Perilous World in Which Boys Become Men,” he found that male college students assumed about 80 percent of their classmates had sex on any given weekend. The real number was closer to 5 percent to 10 percent. The result is a reverse Lake Wobegon effect: Everyone is below “normal.” Rachel Hills, author of “The Sex Myth: The Gap Between Our Fantasies and Reality,” told me that the women she interviewed “have internalized that sex should happen two to three times a week.” In reality, according to the 2010 National Survey of Sexual Health and Behavior, less than half of men and women 18 to 49 in partnered relationships report having sex at least that often."
Emily Nagoski writes in The Medium about the brilliant concept of responsive desire and why pleasure (and not craving) should be Queen:
"The key to assessing your own sexual wellbeing is not how much you want sex, but how much you like the sex you are having. I’m not sure how we got to a place, culturally, where we came to value the craving for sex so much higher than the enjoyment of sex [...] But for me what matters most is that you feel free to let go of the idea that there is a certain amount of “wanting” you’re supposed to be experiencing or else you’re “broken,” and embrace instead the idea that if you’re having fun a the party, you are doing it right."
Here's Azeen Ghorayshi at Buzzfeed on how Even The Score's PR machine co-opted feminist messages to get the drug approved:
"With this multipronged attack, the group has managed to spin the issue of the drug’s approval not in terms of efficacy or side effects (which are not insignificant), but in terms of women’s rights. The group’s strongest assertion, that men have 26 drugs approved to treat sexual dysfunction while women had none, presented a stirring call to arms to “even the score. Trouble is, that figure is patently untrue. As the FDA and many experts on the pharmaceutical industry have pointed out, no drugs are currently on the market to treat low libido in men. (Viagra doesn’t treat sexual desire, but rather a man’s physiological arousal.)"
Lux Alptraum writes in The Motherboard about the Big Business of arousal, and the ways that new products promote secrecy over communication.
"Which is, ultimately, the bitter irony of both flibanserin and Fiera. The products may package themselves in feminist language about empowerment and sexual pleasure, but their business models seem to rely on sexual ignorance, stigma, and a population of women too afraid to actually explore the wealth of other options that might remedy their woes. Those options come at a much cheaper price point than the Fiera, and with far fewer side effects than flibanserin."
And finally, it looks like whether the drug works or not, the original owners of Sprout Pharmaceuticals are getting the last laugh (and a cool $1 billion).